Your browser doesn't support javascript.
loading
LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
Lee, Chia-Huei; Pan, Kao-Lu; Tang, Ya-Chu; Tsai, Ming-Hsien; Cheng, Ann-Joy; Shen, Mei-Ya; Cheng, Ying-Min; Huang, Tze-Ta; Lin, Pinpin.
Afiliación
  • Lee CH; National Institute of Cancer Research, National Health Research Institutes, Taipei, Taiwan.
  • Pan KL; National Institute of Environmental Health Sciences, National Health Research Institutes, Taipei, Taiwan.
  • Tang YC; National Institute of Cancer Research, National Health Research Institutes, Taipei, Taiwan.
  • Tsai MH; National Institute of Environmental Health Sciences, National Health Research Institutes, Taipei, Taiwan.
  • Cheng AJ; Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan City, Taiwan.
  • Shen MY; National Institute of Environmental Health Sciences, National Health Research Institutes, Taipei, Taiwan.
  • Cheng YM; National Institute of Cancer Research, National Health Research Institutes, Taipei, Taiwan.
  • Huang TT; Department of Oral Medicine, National Cheng Kung University, Tainan City, Taiwan.
  • Lin P; National Institute of Environmental Health Sciences, National Health Research Institutes, Taipei, Taiwan.
Oncotarget ; 6(28): 25188-201, 2015 Sep 22.
Article en En | MEDLINE | ID: mdl-26317789
Previously, we identified global epigenetic aberrations in smoking-associated oral squamous cell carcinoma (OSCC). We hypothesized that cigarette exposure triggers OSCC through alteration of the methylome of oral cells. Here we report that cigarette smoke condensate (CSC) significantly changes the genomic 5-methyldeoxycytidine content and nuclear accumulation of DNA methyltransferase 1 (DNMT1) and DNMT3A in human untransformed oral cells. By using integrated analysis of cDNA and methylation arrays of the smoking-associated dysplastic oral cell line and OSCC tumors, respectively, we identified four epigenetic targets--UCHL1, GPX3, LXN, and LDOC1--which may be silenced by cigarette. Results of quantitative methylation-specific PCR showed that among these four genes, LDOC1 promoter was the most sensitive to CSC. LDOC1 promoter hypermethylation and gene silencing followed 3 weeks of CSC treatment. LDOC1 knockdown led to a proliferative response and acquired clonogenicity of untransformed oral cells. Immunohistochemistry showed that LDOC1 was downregulated in 53.3% (8/15) and 57.1% (20/35) of premalignant oral tissues and early stage OSCCs, respectively, whereas 76.5% (13/17) of normal oral tissues showed high LDOC1 expression. Furthermore, the microarray data showed that LDOC1 expression had decreased in the lung tissues of current smokers compared with that in those of never smokers and had significantly decreased in the lung tumors of smokers compared with that in normal lung tissues. Our data suggest that CSC-induced promoter methylation may contribute to LDOC1 downregulation, thereby conferring oncogenic features to oral cells. These findings also imply a tumor suppressor role of LDOC1 in smoking-related malignancies such as OSCC and lung cancer.
Asunto(s)
Biomarcadores de Tumor/genética; Carcinoma de Células Escamosas/genética; Transformación Celular Neoplásica/genética; Silenciador del Gen; Neoplasias de Cabeza y Cuello/genética; Neoplasias Pulmonares/genética; Neoplasias de la Boca/genética; Proteínas Nucleares/genética; Humo/efectos adversos; Fumar/efectos adversos; Fumar/genética; Proteínas Supresoras de Tumor/genética; Biomarcadores de Tumor/metabolismo; Carcinoma de Pulmón de Células no Pequeñas/genética; Carcinoma de Pulmón de Células no Pequeñas/metabolismo; Carcinoma de Pulmón de Células no Pequeñas/patología; Carcinoma de Células Escamosas/metabolismo; Carcinoma de Células Escamosas/patología; Línea Celular Tumoral; Proliferación Celular; Transformación Celular Neoplásica/metabolismo; Transformación Celular Neoplásica/patología; ADN (Citosina-5-)-Metiltransferasa 1; ADN (Citosina-5-)-Metiltransferasas/genética; ADN (Citosina-5-)-Metiltransferasas/metabolismo; Metilación de ADN; ADN Metiltransferasa 3A; Perfilación de la Expresión Génica/métodos; Regulación Enzimológica de la Expresión Génica; Regulación Neoplásica de la Expresión Génica; Neoplasias de Cabeza y Cuello/metabolismo; Neoplasias de Cabeza y Cuello/patología; Humanos; Hiperplasia; Inmunohistoquímica; Neoplasias Pulmonares/metabolismo; Neoplasias Pulmonares/patología; Neoplasias de la Boca/metabolismo; Neoplasias de la Boca/patología; Proteínas Nucleares/metabolismo; Análisis de Secuencia por Matrices de Oligonucleótidos; Regiones Promotoras Genéticas; Interferencia de ARN; Fumar/patología; Carcinoma de Células Escamosas de Cabeza y Cuello; Factores de Tiempo; Análisis de Matrices Tisulares; Transfección; Proteínas Supresoras de Tumor/metabolismo
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Humo / Neoplasias de la Boca / Proteínas Nucleares / Carcinoma de Células Escamosas / Fumar / Biomarcadores de Tumor / Transformación Celular Neoplásica / Silenciador del Gen / Proteínas Supresoras de Tumor / Neoplasias de Cabeza y Cuello Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Humo / Neoplasias de la Boca / Proteínas Nucleares / Carcinoma de Células Escamosas / Fumar / Biomarcadores de Tumor / Transformación Celular Neoplásica / Silenciador del Gen / Proteínas Supresoras de Tumor / Neoplasias de Cabeza y Cuello Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article